Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults
Clinical trial NCT00995540 · TERMINATED
Trial details
- NCT number
- NCT00995540
- Sponsor
- Exsulin Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-12-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.